Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04787445 · ClinicalTrials.gov registry record
Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 19
- Enrollment target
NCT04787445 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 19 participants.
The verdict
NCT04787445 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the clinical and hemodynamic response of Pulmonary Arterial Hypertension (PAH) therapy in patients with atypical PAH and risk factors for left heart disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-03-11 |
| Est. Completion | 2023-11-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04787445
The ClinicalTrials.gov registry entry for NCT04787445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04787445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04787445 about?
NCT04787445 is a clinical study titled "Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension". The purpose of this study is to characterize the clinical and hemodynamic response of Pulmonary Arterial Hypertension (PAH) therapy in patients with atypical PAH and risk factors for left heart disease.
What is the current status of trial NCT04787445?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2021-03-11. Estimated completion is 2023-11-21.
Who is sponsoring clinical trial NCT04787445?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.